TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.480
+0.410 (10.07%)
Nov 21, 2024, 1:34 PM EST - Market open

TriSalus Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
137222313309-
Market Cap Growth
0.29%-29.05%1.52%--
Enterprise Value
136203407--
Last Close Price
4.078.4510.039.88-
PS Ratio
3.6812.0125.2836.75-
PB Ratio
-6.61-8.57-25.439.99-
EV/Sales Ratio
5.0710.9532.84--
Debt / Equity Ratio
-1.15-0.06-0.16--0.84
Asset Turnover
0.880.780.410.37-
Inventory Turnover
1.231.301.631.28-
Quick Ratio
1.631.040.344.970.09
Current Ratio
2.401.420.535.510.11
Return on Equity (ROE)
---507.96%--
Return on Assets (ROA)
-96.32%-141.84%-76.13%-65.35%-
Return on Capital (ROIC)
-445.33%--221.73%-131.01%-
Earnings Yield
-45.32%-26.55%-15.05%-9.34%-
FCF Yield
-35.98%-22.77%-10.52%-7.71%-
Buyback Yield / Dilution
-578.00%-2934.71%96.51%-15.52%-
Total Shareholder Return
-578.00%-2934.71%96.51%-15.52%-
Source: S&P Capital IQ. Standard template. Financial Sources.